Release Date: 23/05/17 15:09 Summary: Renounceable Rights Offer Closure / Notice of Shortfall Price Sensitive: No Download Document 300.6KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%